Literature DB >> 28011143

Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis.

Elisa Martini1, Maria Wikén2, Stanley Cheuk2, Irène Gallais Sérézal1, Faezzah Baharom2, Mona Ståhle1, Anna Smed-Sörensen2, Liv Eidsmo3.   

Abstract

Epidermal Langerhans cells (LCs) are spatially separated from dermal dendritic cells (DCs) in healthy human skin. In active psoriasis, maintained by local production of IL-23 and IL-17, inflammatory DCs infiltrate both skin compartments. Here we show that CCR2+ epidermal DCs (eDCs) were confined to lesional psoriasis and phenotypically distinct from dermal DCs. The eDCs exceeded the number of LCs and displayed high expression of genes involved in neutrophil recruitment and the activation of keratinocytes and T cells. Resident LCs responded to toll-like receptor 4 and toll-like receptor 7/8 activation with increased IL-23 production, whereas eDCs additionally produced IL-1β together with IL-23 and tumor necrosis factor. Psoriasis typically recur in fixed skin lesions. eDCs were absent from resolved psoriasis. Instead, LCs from anti-tumor necrosis factor-treated lesions retained high IL23A expression and responded to toll-like receptor stimulation by producing IL-23. Our results reveal phenotypic and functional properties of eDCs and resident LCs in different clinical phases of psoriasis, and the capacity of these cells to amplify the epidermal microenvironment through the secretion of IL-17 polarizing cytokines.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28011143     DOI: 10.1016/j.jid.2016.11.033

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

Review 1.  Ontogeny and function of murine epidermal Langerhans cells.

Authors:  Daniel H Kaplan
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

Review 2.  Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

Review 3.  Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders.

Authors:  Ling Chen; Zhu Shen
Journal:  Cell Mol Immunol       Date:  2019-10-08       Impact factor: 11.530

Review 4.  The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis.

Authors:  Tae-Gyun Kim; Sung Hee Kim; Min-Geol Lee
Journal:  Int J Mol Sci       Date:  2017-12-23       Impact factor: 5.923

Review 5.  Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions.

Authors:  Liv Eidsmo; Elisa Martini
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

Review 6.  Immunological Memory of Psoriatic Lesions.

Authors:  Agnieszka Owczarczyk Saczonek; Magdalena Krajewska-Włodarczyk; Marta Kasprowicz-Furmańczyk; Waldemar Placek
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

7.  MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease.

Authors:  Weiheng Zhao; Shuxiu Xiao; Hongjin Li; Tingting Zheng; Jian Huang; Ran Hu; Baohua Zhang; Xinguang Liu; Gonghua Huang
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

Review 8.  Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease).

Authors:  Theresa Benezeder; Peter Wolf
Journal:  Semin Immunopathol       Date:  2019-10-31       Impact factor: 9.623

9.  Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis.

Authors:  Kevin Fenix; Danushka K Wijesundara; Allison J Cowin; Branka Grubor-Bauk; Zlatko Kopecki
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

Review 10.  New Treatment Addressing the Pathogenesis of Psoriasis.

Authors:  Michio Tokuyama; Tomotaka Mabuchi
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.